Authors:
Ueda, K
Ishida, M
Fujimoto, M
Kawahara, Y
Sakaeda, T
Iwakawa, S
Citation: K. Ueda et al., Effect of injection volume on the pharmacokinetics of oil particles and incorporated menatetrenone after intravenous injection as O/W lipid emulsionsin rats, J DRUG TAR, 9(5), 2001, pp. 353-360
Authors:
Iida, N
Takara, K
Ohmoto, N
Nakamura, T
Kimura, T
Wada, A
Hirai, M
Sakaeda, T
Okumura, K
Citation: N. Iida et al., Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells, BIOL PHAR B, 24(9), 2001, pp. 1032-1036
Authors:
Sakaeda, T
Okamura, N
Nagata, S
Yagami, T
Horinouchi, M
Okumura, K
Yamashita, F
Hashida, M
Citation: T. Sakaeda et al., Molecular and pharmacokinetic properties of 222 commercially available oral drugs in humans, BIOL PHAR B, 24(8), 2001, pp. 935-940
Authors:
Nakamura, T
Kakumoto, M
Sakaeda, T
Nagahiro, K
Ohmichi, R
Yamashita, K
Nishiguchi, K
Hirai, M
Okumura, K
Citation: T. Nakamura et al., Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients, BIOL PHAR B, 24(6), 2001, pp. 683-687
Authors:
Kita, T
Tanigawara, Y
Chikazawa, S
Hatanaka, H
Sakaeda, T
Komada, F
Iwakawa, S
Okumura, K
Citation: T. Kita et al., N-acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients, BIOL PHAR B, 24(5), 2001, pp. 544-549
Authors:
Kita, T
Sakaeda, T
Adachi, S
Sakai, T
Aoyama, N
Hatanaka, H
Kasuga, M
Okumura, K
Citation: T. Kita et al., N-acetyltransferase 2 genotype correlates with sulfasarazine pharmacokinetics after multiple dosing in healthy Japanese subjects, BIOL PHAR B, 24(10), 2001, pp. 1176-1180
Authors:
Sakai, T
Aoyama, N
Kita, T
Sakaeda, T
Nishiguchi, K
Nishitora, Y
Hohda, T
Sirasaka, D
Tamura, T
Tanigawara, Y
Kasuga, M
Okumura, K
Citation: T. Sakai et al., CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects, PHARM RES, 18(6), 2001, pp. 721-727
Authors:
Kita, T
Tanigawara, Y
Aoyama, N
Hohda, T
Saijoh, Y
Komada, F
Sakaeda, T
Okumura, K
Sakai, T
Kasuga, M
Citation: T. Kita et al., CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability, PHARM RES, 18(5), 2001, pp. 615-621
Authors:
Sakaeda, T
Nakamura, T
Horinouchi, M
Kakumoto, M
Ohmoto, N
Sakai, T
Morita, Y
Tamura, T
Aoyama, N
Hirai, M
Kasuga, M
Okumura, K
Citation: T. Sakaeda et al., MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects, PHARM RES, 18(10), 2001, pp. 1400-1404
Authors:
Kawakami, S
Nishida, K
Mukai, T
Yamamura, K
Nakamura, J
Sakaeda, T
Nakashima, M
Sasaki, H
Citation: S. Kawakami et al., Controlled release and ocular absorption of tilisolol utilizing ophthalmicinsert-incorporated lipophilic prodrugs, J CONTR REL, 76(3), 2001, pp. 255-263
Authors:
Tanigawara, Y
Kita, T
Hirono, M
Sakaeda, T
Komada, F
Okumura, K
Citation: Y. Tanigawara et al., Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood, THER DRUG M, 23(4), 2001, pp. 341-346
Authors:
Kawakami, S
Yamamura, K
Mukai, T
Nishida, K
Nakamura, J
Sakaeda, T
Nakashima, M
Sasaki, H
Citation: S. Kawakami et al., Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes, J PHARM PHA, 53(8), 2001, pp. 1157-1161
Authors:
Yagami, T
Ueda, K
Asakura, K
Sakaeda, T
Kuroda, T
Hata, S
Kambayashi, Y
Fujimoto, M
Citation: T. Yagami et al., Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloidbeta protein-induced neuronal cell death, BR J PHARM, 134(3), 2001, pp. 673-681
Authors:
Sakaeda, T
Siahaan, TJ
Audus, KL
Stella, VJ
Citation: T. Sakaeda et al., Enhancement of transport of D-melphalan analogue by conjugation with L-glutamate across bovine brain microvessel endothelial cell monolayers, J DRUG TAR, 8(3), 2000, pp. 195-204
Authors:
Takara, K
Tanigawara, Y
Komada, F
Nishiguchi, K
Sakaeda, T
Okumura, K
Citation: K. Takara et al., The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein, JPN J CANC, 91(2), 2000, pp. 248-254
Authors:
Takara, K
Tanigawara, Y
Komada, F
Nishiguchi, K
Sakaeda, T
Okumura, K
Citation: K. Takara et al., Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs, BIOL PHAR B, 22(12), 1999, pp. 1355-1359
Authors:
Sakaeda, T
Fukumura, K
Takahashi, K
Matsumura, S
Matsuura, E
Hirano, K
Citation: T. Sakaeda et al., Blood flow rate in normal and tumor-bearing rats in conscious state, underurethane anesthesia, and during systemic hypothermia, J DRUG TAR, 6(4), 1998, pp. 261-272
Citation: T. Sakaeda et K. Hirano, Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions, J DRUG TAR, 6(4), 1998, pp. 273-284
Authors:
Sakaeda, T
Kakushi, H
Shike, T
Takano, K
Harauchi, T
Hirata, M
Hirano, K
Citation: T. Sakaeda et al., O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone, J DRUG TAR, 6(3), 1998, pp. 183-189
Citation: T. Sakaeda et K. Hirano, O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection, J DRUG TAR, 6(2), 1998, pp. 119-127